Expression of fibronectin and HIF-1α in renal cell carcinomas: relationship to von Hippel-Lindau gene inactivation
- 15 July 2004
- journal article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 152 (2) , 89-94
- https://doi.org/10.1016/j.cancergencyto.2003.11.001
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel–Lindau proteinNature Cell Biology, 2000
- The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysisNature, 1999
- Advances in the molecular basis of renal neoplasiaCurrent Opinion in Nephrology and Hypertension, 1999
- Inactivation of the von Hippel–Lindau ( VHL ) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: Evidence for a VHL ‐independent pathway in clear cell renal tumourigenesisGenes, Chromosomes and Cancer, 1998
- Regulation of Hypoxia-Inducible mRNAs by the von Hippel-Lindau Tumor Suppressor Protein Requires Binding to Complexes Containing Elongins B/C and Cul2Molecular and Cellular Biology, 1998
- Molecular genetics of human renal cell tumoursNephrology Dialysis Transplantation, 1996
- Somatic mutations of von Hippel‐Lindau (VHL) tumor‐suppressor gene in european kidney cancersInternational Journal of Cancer, 1995
- Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.Proceedings of the National Academy of Sciences, 1994
- Mutations of the VHL tumour suppressor gene in renal carcinomaNature Genetics, 1994
- Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinomaNature, 1987